Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

32
Number of overlapping holdings
82.1%
% of XPH's 39 holdings also in IHE
94.1%
% of IHE's 34 holdings also in XPH
Overlap by Weight
Sector Drift (XPH minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XPH |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 5.1% | 26.1% | 5.1% | |
JOHNSON & JOHNSON | 4.8% | 23.4% | 4.8% | |
ZOETIS INC | 4.9% | 4.7% | 4.7% | |
MERCK & CO. INC. | 4.7% | 4.7% | 4.7% | |
ROYALTY PHARMA PLC CLASS A | 4.7% | 4.6% | 4.6% |
Position Highlights (Non-Overlapping Exposures)
XPH Overweight Relative to IHE
INTRA-CELLULAR THERAPIES INC | 2.8% | |
AXSOME THERAPEUTICS, INC. | 2.8% | |
PERRIGO CO | 2.8% | |
ELANCO ANIMAL HEALTH, INC. | 2.6% | |
CYMABAY THERAPEUTICS, INC. | 2.6% | |
AMPHASTAR PHARMACEUTICALS INC | 2.5% | |
CASSAVA SCIENCES, INC. | 2.0% | |
REVANCE THERAPEUTICS INC | 1.8% | |
AMYLYX PHARMACEUTICALS, INC. | 1.8% | |
ORGANON & CO. | 1.7% |
XPH Underweight Relative to IHE
ELI LILLY & CO | -20.9% | |
JOHNSON & JOHNSON | -18.7% | |
ATEA PHARMACEUTICALS, INC. | -0.1% | |
PHIBRO ANIMAL HEALTH CORP-A | -0.1% | |
MERCK & CO. INC. | 0.0% | |
BRISTOL-MYERS SQUIBB CO | 0.1% | |
ACLARIS THERAPEUTICS, INC. | 0.1% | |
ROYALTY PHARMA PLC CLASS A | 0.1% | |
VENTYX BIOSCIENCES, INC. | 0.1% | |
VIATRIS, INC. | 0.2% |